The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer
Open Access
- 23 August 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-6
Abstract
The serum macrophage inhibitory cytokine-1 (MIC-1) levels are elevated in some inflammatory conditions and cancers. We thus compared the levels of biliary and serum MIC-1 and conventional tumour markers between 23 biliary tract cancer (BTC) patients (malignant group) and 29 benign biliary disease patients (benign group) and found that all markers were significantly elevated in the malignant group. The levels of two markers were higher in early BTC (Stage I/II, n = 15) than in the benign group: biliary MIC-1 [12 (0–2153) vs. 678 (0–4429) pg/ml, P < 0.01] and serum CA19–9 [13 (2–15,682) vs. 45.1 (2–10,478) U/ml, P = 0.02]. A receiver operating characteristic curve analysis revealed that the area under the curve for biliary MIC-1 was greater than that for serum CA19-9 (0.77 vs. 0.73). The cut-off value for biliary MIC-1 in diagnosing early BTC was 581.6 pg/ml, and this value yielded a sensitivity, specificity and accuracy of 71.4%, 82.8%, and 79.1%, respectively. The sensitivity of biliary MIC-1 for diagnosing early BTC was superior to that of biliary cytology (71.4% vs. 8.33%, P < 0.01), and the combination of serum MIC-1 with CA19-9 (cut-off value = 4021.2 pg/ml, 42.4 U/ml) was useful for screening BTC (sensitivity = 82.6%, specificity = 72.4%). In conclusion, biliary MIC-1 can effectively diagnose early BTC.Keywords
This publication has 24 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- How many cytological examinations should be performed for the diagnosis of malignant biliary stricture via an endoscopic nasobiliary drainage tube?Journal of Gastroenterology and Hepatology, 2008
- Role of Macrophage Inhibitory Cytokine-1 in Tumorigenesis and Diagnosis of CancerCancer Research, 2006
- Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary CancersClinical Cancer Research, 2004
- Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2)Gastrointestinal Endoscopy, 2002
- Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2)Gastrointestinal Endoscopy, 2002
- Prospective Evaluation of Brush Cytology of Biliary Strictures During Endoscopic Retrograde CholangiopancreatographyEndoscopy, 1999
- Complete tissue sampling of biliary strictures at ERCP using a new deviceGastrointestinal Endoscopy, 1996
- Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective studyGastrointestinal Endoscopy, 1995
- Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective studyGastrointestinal Endoscopy, 1995